1. WHO. WHO Alliance for Global Elimination of Blinding Trachoma by 2020: Weekly epidemiological record 2014; 39(89):421–428.
2. Mariotti SP, Pascolini D, Rose-Nussbaumer J. Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol. 2009;93:563–8.
3. Carter Center. Summary Proceedings: Eleventh Annual Trachoma Control Program Review; Planning for Trachoma Elimination, District by District; 2010.URL:
http://www.cartercenter.org/resources/pdfs/news/health_publications/trachoma/trachreview_final_eng2010.pdf
(Accessed on December 2012).
4. FMOH. National survey on blindness, Low Vision and Trachoma in Ethiopia; 2006.
http://pbunion.org/Countriessurveyresults/Ethiopia/Ethiopian_National_Blindness_and_trachoma_survey.pdf
(Accessed on 05 DeC 2012).
5. Darougar S, Jones BR, Viswalingam M, et al. Topical therapy of hyper endemic trachoma with rifampicin, oxytetracycline or spiramycin eye ointments. Br J Ophthalmol. 1980;64:37–42.